Well Peter, you have set yourself a conundrum, haven't you? On the one hand, revenue is critical to you view of an investment (and fair enough), but on the other hand you are invested in a company, where the CEO shows many positive attributes and forward thinking capabilities. But enlightening the market re future specific revenue prospects is clearly not something he sees himself addressing any time soon. In which case, well I just hope you get the balance of medications right.
And seriously, as we head into the quarterly reporting season, if any one is looking for significant revenue outcomes to justify or boost their SYT investments...well, if you've DYOR'd, you already know that isn't going to happen.
IMO, we are riding a market-changing animal here. One which many of us believe can be very, no, incredibly, worthwhile in the long term. But until the market grasps the logic behind the SYT value proposition, we need patience more than we need skills of revenue analysis.
Think about it.
SYT Price at posting:
3.6¢ Sentiment: Hold Disclosure: Held
